Since, the GLI transcription factors can integrate with other oncogenic signaling cascades and promote cancer progression and malignant properties of cancer (stem) cells [5,6,34,38,39,40,60,62,65], oncogenic GLI transcription factors represent attractive therapeutic targets for patients with acquired and a priori resistance to SMOi. Here, GLI1 is linked to cancer.